https://orcid.org/0000-0002-6383-8308
References
- Akiyama, M. J., Spaulding, A. C., & Rich, J. D. (2020). Flattening the curve for incarcerated populations-Covid-19 in jails and prisons. The New England Journal of Medicine, 382(22), 2075–2077. https://doi.org/10.1056/NEJMp2005687
- Alinejad, S., Kazemi, T., Zamani, N., Hoffman, R. S., & Mehrpour, O. (2015). A systematic review of the cardiotoxicity of methadone. EXCLI Journal, 14, 577–600. https://doi.org/10.17179/excli2015-553
- Babu, K. M., Brent, J., & Juurlink, D. N. (2019). Prevention of opioid overdose. The New England Journal of Medicine, 380(23), 2246–2255. https://doi.org/10.1056/NEJMra1807054
- Giudicessi, J. R., Noseworthy, P. A., Friedman, P. A., & Ackerman, M. J. (2020). Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for Coronavirus Disease 19 (COVID-19. Mayo Clinic Proceedings, 95(6), 1213–1221. https://doi.org/10.1016/j.mayocp.2020.03.024
- Juurlink, D. N. (2020). Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Cmaj : Canadian Medical Association Journal = Journal de L'association Medicale Canadienne, 192(17), E450–E453. https://doi.org/10.1503/cmaj.200528
- Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., & Fischer, B. (2019). Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. PLOS Medicine, 16(12), e1003002. https://doi.org/10.1371/journal.pmed.1003002
- Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., Barnaby, D. P., Becker, L. B., Chelico, J. D., Cohen, S. L., Cookingham, J., Coppa, K., Diefenbach, M. A., Dominello, A. J., Duer-Hefele, J., Falzon, L., Gitlin, J., Hajizadeh, N., Harvin, T. G., … Zanos, T. P. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA, 323(20), 2052. https://doi.org/10.1001/jama.2020.6775
- Roy, S., Ninkovic, J., Banerjee, S., Charboneau, R. G., Das, S., Dutta, R., Kirchner, V. A., Koodie, L., Ma, J., Meng, J., & Barke, R. A. (2011). Opioid drug abuse and modulation of immune function: Consequences in the susceptibility to opportunistic infections. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 6(4), 442–465. https://doi.org/10.1007/s11481-011-9292-5
- Tsai, J., & Wilson, M. (2020). COVID-19: A potential public health problem for homeless populations. The Lancet. Public Health, 5(4), e186–e187. https://doi.org/10.1016/S2468-2667(20)30053-0
- Vallejo, R., de Leon-Casasola, O., & Benyamin, R. (2004). Opioid therapy and immunosuppression: A review. American Journal of Therapeutics, 11(5), 354–365. https://doi.org/10.1097/01.mjt.0000132250.95650.85
- Volkow, N. D. (2020). Collision of the COVID-19 and addiction epidemics. Annals of Internal Medicine, M20–1212. https://doi.org/10.7326/M20-1212
- Yamamoto, A., Needleman, J., & Gelberg, L. (2019). Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits. Social Science & Medicine, 242, 112585.
- Ye, Q., Wang, B., & Mao, J. (2020). The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. Journal of Infection, 80(6), 607–613.
- Zhao, J., Zhao, J., & Perlman, S. (2010). T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. Journal of Virology, 84(18), 9318–9325. https://doi.org/10.1128/JVI.01049-10